Eduardo Groisman
- Yale University · Microbiology & Immunology (NIH department code)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
FY2024 NIH rank #13,921
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1877969Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Microbiology & Immunology
NIH Funding · FY2024
Linked Award Amount
$1.1M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#13,921
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Eduardo Groisman as a PI. Multi-PI records show the full award amount for context.
- 5R01AI049561-32R01Contact PIHow Regulated Proteolysis Controls Bacterial VirulenceYale University · Microbiology & Immunology (NIH department code)$521.9Kaward amount
- 5R01GM123798-07R01Contact PIControl of gut colonization by the prominent gut bacterium Bacteroides thetaiotaomicronYale University · Microbiology & Immunology (NIH department code)$339.4Kaward amount
- 5R21AI173914-02R21Contact PIA Novel High-Throughput Exploration of DNA Supercoiling toward the Therapeutic Manipulation of BacteriaYale University · Microbiology & Immunology (NIH department code)$209.4Kaward amount
Award organization
Organizations that administered FY2024 awards listing Eduardo Groisman as a PI.
FY2024 award administered by Yale University (CT).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardYale University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #2702
- 2025Entered Top 25% NationallyRanked #2702
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding